Functional expression of adrenoreceptors in mesenchymal stromal cells derived from the human adipose tissue  by Kotova, Polina D. et al.
Biochimica et Biophysica Acta 1843 (2014) 1899–1908
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamcrFunctional expression of adrenoreceptors in mesenchymal stromal cells
derived from the human adipose tissuePolina D. Kotova a, Veronika Yu. Sysoeva b, Olga A. Rogachevskaja a, Marina F. Bystrova a, Alisa S. Kolesnikova a,
Pyotr A. Tyurin-Kuzmin b, Julia I. Fadeeva b, Vsevolod A. Tkachuk b, Stanislav S. Kolesnikov a,⁎
a Institute of Cell Biophysics, Russian Academy of Sciences, Pushchino, Moscow Region 142290, Russia
b Department of Biochemistry and Molecular Medicine, Faculty of Basic Medicine, Lomonosov Moscow State University, Russia⁎ Corresponding author at: Institute of Cell Biophysics
Institutional Street 3, Pushchino, Moscow Region 142290
fax: +7 96 733 0509.
E-mail address: staskolesnikov@yahoo.com (S.S. Koles
http://dx.doi.org/10.1016/j.bbamcr.2014.05.002
0167-4889/© 2014 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 1 March 2014
Received in revised form 1 May 2014
Accepted 9 May 2014
Available online 16 May 2014
Keywords:
Mesenchymal stromal cell
Adrenergic receptor
Calcium-induced calcium release
Ca2+ uncaging
IP3 receptorCulturedmesenchymal stromal cells (MSCs) fromdifferent sources represent a heterogeneous population of pro-
liferating non-differentiated cells that contains multipotent stem cells capable of originating a variety of mesen-
chymal cell lineages. Despite tremendous progress inMSC biology spurred by their therapeutic potential, current
knowledge on receptor and signaling systems of MSCs is mediocre. Here we isolated MSCs from the human
adipose tissue and assayed their responsivity to GPCR agonists with Ca2+ imaging. As a whole, a MSC population
exhibited functional heterogeneity. Although a variety of ﬁrst messengers was capable of stimulating Ca2+
signaling inMSCs, only a relatively small group of cellswas speciﬁcally responsive to the particular GPCR agonist,
including noradrenaline. RT-PCR and immunocytochemistry revealed expression of α1B-, α2A-, and β2-
adrenoreceptors inMSCs. Their sensitivity to subtype-speciﬁc adrenergic agonists/antagonists and certain inhib-
itors of Ca2+ signaling indicated that largely the α2A-isoform coupled to PLC endowed MSCs with sensitivity to
noradrenaline. The all-or-nothing dose-dependencewas characteristic of responsivity of robust adrenergicMSCs.
Noradrenaline never elicited small or intermediate responses but initiated large and quite similar Ca2+ transients
at all concentrations above the threshold. The inhibitory analysis and Ca2+ uncaging implicated Ca2+-induced
Ca2+ release (CICR) in shaping Ca2+ signals elicited by noradrenaline. Evidence favored IP3 receptors as predom-
inantly responsible for CICR. Based on the overall ﬁndings, we inferred that adrenergic transduction in MSCs
includes two fundamentally different stages: noradrenaline initially triggers a local and relatively small Ca2+
signal, which next stimulates CICR, thereby being converted into a global Ca2+ signal.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Apart from fully differentiated cells, apparently all postnatal mam-
malian tissues contain rare and quiescent stem cells that have the
capacity for self-renewal and initiating differentiated descendants [1,
2]. Mesenchymal stem cells are an uncommon population present in
the bone marrow and tissues, such as the adipose tissue, synovium,
dermis, periosteum, and deciduous teeth. During isolation and expan-
sion in vitro mesenchymal stem cells constitute a minor fraction
(b1%) of the total mesenchymal stromal cell (MSC) population. The in-
creasing body of evidence points to the intrinsic, and donor-to-donor
heterogeneity of MSC populations [3–5]. One of the pioneering demon-
strations of populational diversity was provided by the microSAGE
assay of MSC colonies derived from a single human bone marrow cell.
The expression analysis revealed transcripts for more than 2000 genes, Russian Academy of Sciences,
, Russia. Tel.: +7 96 773 9121;
nikov).encoding proteins known to regulate angiogenesis, cell motility, hema-
topoiesis, immunity, and neural activities [6,7]. It seems to be highly
unlikely if an individual cell would be capable of fulﬁlling all these
autonomous physiological functions. Consistently, immunostaining
data suggested a non-uniform pattern of protein expression [7]. It was
therefore postulated that a variety of functional attributes character-
istic of the entire MSC population was determined by separate sub-
populations. The concept of intrinsic heterogeneity of a MSC popula-
tion is well consistent with the ﬁnding that a MSC colony can release
a broad array of signaling molecules, including FGF-2, BDNF, IGF1,
ANG1 and certain cytokines and chemokines [8]. Althoughmammalian
MSCs are poorly characterized in terms of intracellular signaling and
ionic mechanisms of electrogenesis, available reports also evidence for
molecular and functional heterogeneity of MSC populations [9,10].
Several key factors determine cell proliferation and differentiation,
including intrinsic genetic programs, intracellular signaling, and local
environmental cues. Reportedly, spontaneous Ca2+ oscillations and
induced Ca2+ transients can mediate development, from fertilization
throughproliferation anddifferentiation to organogenesis, and expansion
of progenitor pools [11–13]. Thus, membrane receptors and regulatory
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portant for tissue development and regeneration. Although a role of ion
channels is much less obvious, they may also be involved in coordinating
extracellular and intracellular signals associated with cell proliferation
and differentiation [10,14–16]. Speciﬁcally, ion channels can regulate
exocytosis of autocrine and paracrine factors by determining membrane
potential and Ca2+ inﬂux [16]. Transmembrane ion ﬂuxes drive cell
volume oscillations in cycling and migrating cells [17,18]. Yet, ion chan-
nels are capable of modulating cell proliferation and differentiation via
ﬂux-independent mechanisms, including association of channel proteins
with membrane receptors and related proteins [19–22].
In light of molecular and functional heterogeneity of a MSC popula-
tion posed by the abovementioned facts, the important possibility is
that molecular and functional phenotypes of these cells may be in
strong correlation. If so, an individualMSC subpopulationwith a speciﬁc
molecular proﬁle could be revealed physiologically and described in
terms of responsivity to agonists, Ca2+ signaling pathways, and/or
activity of ion channels.We therefore attempted to characterize respon-
siveness of adipose-derived human MSCs to a variety of agonists, such
as ACh, ATP, noradrenaline, serotonin, and some others, which are
known to mobilize cytosolic Ca2+ in cells of diverse types. All ﬁrst mes-
sengers probed by us were found to stimulate Ca2+ signaling in MSCs.
Since apart from ATP, a given cell usually responded to one of them, it
appears that different MSC subpopulations can indeed be classiﬁed
based on functional criteria. Here we focused largely on the analysis of
MSCs responsive to noradrenaline, given some interesting aspects of
Ca2+ signaling in adrenergic cells.
2. Materials and methods
2.1. Cell isolation and culturing
Human MSCs were isolated from abdominal subcutaneous adipose
tissue harvested during surgical operations from patients at age within
32–60 years. All donors gave informed consent for harvesting their
adipose tissue. Donors with infectious or systemic diseases and malig-
nancies were not included in the study. Adipose tissue was extensively
washed with 2 volumes of Hank's Balanced Salt Solution (HBSS) con-
taining 1% antibiotic/antimycotic solution (HyClone) and then digested
at 37 °C for 1 h in the presence of collagenase (66.7 U/ml, Sigma-
Aldrich) and dispase (10 U/ml, BD Biosciences). Enzymatic activity
was neutralized by adding an equal volume of culture medium
(AdvanceStembasalmedium for human undifferentiatedmesenchymal
stem cells (HyClone) containing 10% of Advance stem cell growth
supplement (CGS) (HyClone), 1% antibiotic/antimycotic solution) and
centrifuged at 200 g for 10 min. This led to sedimentation of diverse
cells, including MSCs, macrophages, lymphocytes, and erythrocytes,
whilemature adipocytes remainedﬂoating. After removal of supernatant,
a lysis solution (154 mM NH4Cl, 10 mM KHCO3, and 0.1 mM EDTA) was
added to a cell pellet to lyse erythrocytes, and cell suspension was centri-
fuged at 200 g for 10min. Sedimented cells were resuspended in theMSC
culture medium and ﬁltered through a 100 μm nylon cell strainer (BD
Biosciences). As indicated by ﬂow cytometry data (Supplementary
Materials, Fig. 1S), after isolation and overnight pre-plating, the obtained
cell population contained largely not only MSC cells but also macro-
phages and lymphocytes. The two last cell groups were dramatically de-
pleted by culturing during 1 week in the MSC culture medium and
humidiﬁed atmosphere (5% CO2) at 37 °C. The obtainedMSC population
was maintained at a sub-conﬂuent level (b80% conﬂuency) and pas-
saged using HyQTase (HyClone). For experiments, cells of the second to
fourth passages were used.
2.2. Preparation of cells for Ca2+ imaging
Before assaying with Ca2+ imaging, cells were maintained in a 12-
socket plate for 12 h in the medium described above but withoutantibiotics. For isolation, cells cultured in a 1 ml socket were rinsed
twice with the Versen solution (Sigma-Aldrich) that was then substitut-
ed for 0.2 ml HyQTase solution (HyClone) for 3–5 min. The enzymatic
treatment was terminated by the addition of a 0.8 ml culture medium
to a socket. Next, cellswere resuspended, put into a tube, and centrifuged
at 0.8 g for 45 s for sedimentation. Isolated cells were collected by a
plastic pipette and plated onto a recording chamber of nearly 150 μl
volume. The last was a coverslip (Menzel-Glaser) with attached ellip-
soidal resin wall. The chamber bottom was coated with Cell-Tak (BD
Biosciences) allowing for strong cell adhesion. Attached cells were
then loaded with dyes at room temperature (23–25 °С) by adding
Fluo-4AM (4 μM) or Fluo-4AM (4 μM) + NP-EGTA-AM (4 μM) and
Pluronic (0.02%) (all from Molecular Probes) to the bath solution
(mM): NaCl — 110, KCl — 5.5, CaCl2 — 2, MgSO4 — 0.8, HEPES — 10,
and glucose — 10, pH 7.4. After 20-min incubation cells were rinsed
several times with the bath solution and stored at 4 °С for 40 min.
When necessary, 2 mM CaCl2 in the bath solution was replaced
with 0.5 mМ EGTA+0.4mМ CaCl2, thus reducing free Ca2+ to nearly
260 nM.
2.3. Ca2+ imaging and uncaging
Most of experiments were carried out using an inverted ﬂuorescent
microscope Axiovert 135 equipped with an objective Plan NeoFluar
20x/0.75 (Zeiss) and a digital ECCD camera LucaR (Andor Technology).
Apart from a transparent light illuminator, the microscope was
equipped with a hand-made system for epi-illumination via an objec-
tive. The epi-illumination was performed using a bifurcational glass
ﬁber. One channel, which was used for Fluo-4 excitation, transmitted
480 ± 5 nm irradiation emitted by LED controlled by a computer.
Fluo-4 emissionwas collected at 535±20nm. Serialﬂuorescent images
were captured every second and analyzed using Imaging Workbench 6
software (INDEC). Deviations of cytosolic Ca2+ from the resting level
were quantiﬁed by a relative change in the intensity of Fluo-4 ﬂuores-
cence (ΔF/F0) recorded from an individual cell. Another channel was
connected to a pulsed solid laser DTL-374QT (30 mW) (Laser-Export,
Moscow). This unit operated in a two-harmonic mode and generated
not only 355 nM UV light used for Ca2+ uncaging but also visible light
at 532 nm. The last could penetrate into an emission channel through
non-ideal optical ﬁlters and elicited optical artifacts during uncaging.
For Ca2+ uncaging, cells were loaded with both 4 μM Fluo-4 and
NP-EGTA (both from Invitrogen). Other compounds were from
Sigma-Aldrich or Tocris.
2.4. Immunoﬂuorescent analysis
For immunoﬂuorescence analysis cultured cells were washed with
PBS and ﬁxed in 4% formaldehyde for 4 min at room temperature.
Cells were then washed with PBS. Nonspeciﬁc binding was blocked by
incubation in 1% BSA with 10% serum of secondary antibody donor for
30 min. Immunostaining was performed using mouse antibody against
human α1-adrenoreceptor (Abbiotec) and rabbit polyclonal antibody
against the human α2-adrenoreceptor (Thermo Sci). Cells stained
with primary antibodies were then incubated in the presence of
secondary antibodies, Alexa goat anti-rabbit 488 (Molecular Probes,
Carlsbad, CA) or Alexa goat anti-mouse 488 (Molecular Probes). Cells
were counterstained with nuclear 4,6-diamidino-2-phenylindole
(Molecular Probes). As a negative control, cells were treated with
mouse or rabbit nonspeciﬁc IgGs at relevant concentrations. Immuno-
ﬂuorescence was captured using a Leica DM6000microscope equipped
with a Leica DFC360 FX camera and Las AF software (Leica).
2.5. RT-PCR
Total RNAwas extracted from a sample containing 105–106MSCs by
using the RNeasy mini kit (Qiagen). Isolated RNA was treated with
Fig. 1. Functional heterogeneity of mesenchymal stromal cells (MSCs) derived from the
human adipose tissue. (A–E) Representative recordings of intracellular Ca2+ in Fluo-4
loaded cells and their responses to the particular agonist applied as indicated by the hor-
izontal lines. (F) Representative recording from a cell generating spontaneous Ca2+ oscil-
lations. In A–F, 6 different cells were assayed simultaneously; the shown traces are
similarly scaled in time. (G) Fractional distribution of 302 MSCs, each being responsive
to the particular agonist. Here, ATP— 10 μMadenosine triphosphate, Aden— 10 μMaden-
osine, Carb — 20 μM carbachol, GABA — 20 μM gamma-aminobutyric acid, Glut — 10 μM
glutamic acid, Nor — 0.5 μM noradrenaline, Ser — 10 μM serotonin. Here and below, the
data are presented asΔF/F0, whereΔF= F F0, F is the instant intensity of cellﬂuorescence,
and F0 is the intensity of cell ﬂuorescence obtained in the very beginning of a recording
and averaged over a 20-s interval.
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transcriptase (Invitrogen), following the manufacturer's instruction.
Obtained cDNA served as a template for PCRwith gene-speciﬁc primers
that were designed for all human adrenoreceptor genes and for some
marker genes, including CD73, CD90, and CD105 (Supplementary
Materials, Table 1S). The expected sizes of PCR products were as
follows: 259 bp for ADRA1A (α1A), 379 bp for ADRA1B (α1B), 285 bp
for ADRA1D (α1D), 347 bp for ADRA2A (α2A), 353 bp for ADRA2B
(α2B), 291 bp for ADRA2C (α2C), 397 bp for ADRB1 (β1), 218 bp for
ADRB2 (β2), 361 bp for ADRB3 (β3), 266 bp for CD73, 344 bp for
CD90, and 300 bp for CD105.
3. Results
We loaded human MSCs with Fluo-4 and assayed their responsivity
to different messengers using Ca2+ imaging. Functional heterogeneity
was characteristic of MSCs. Although a variety of GPCR agonists was
found to stimulate Ca2+ signaling in MSCs, in a whole MSC population,
only a relatively small group of cells was speciﬁcally responsive to the
particular agonist, including ATP, noradrenaline or adrenaline, sero-
tonin, GABA, acetylcholine or its analog carbachol (Fig. 1), and gluta-
mate (not shown). Basically, a given cell was either irresponsive to
all stimuli or responded to one, rarely two, particular compound
(Fig. 1A–E). When applied shortly, a given neurotransmitter typical-
ly triggered a Ca2+ transient in a responsive cell (Fig. 1A–E). Overall,
958 MSCs were sequentially stimulated by multiple agonists, and
302 cells (31%) responded to some of them. In a subpopulation of
irresponsiveMSCs, certain cells (2–5% depending on a sample) generated
spontaneous Ca2+ oscillations under our recording conditions (Fig. 1F).
ATP-sensitive cells (n = 112) composed the most abundant subgroup
(37%), while adenosine and glutamate were the least effective agonists,
being capable of mobilizing intracellular Ca2+ solely in 8 (2.6%) and 11
(3.6%) cells, respectively (Fig. 1G).
Here we focused on adrenergic signaling in MSCs. Because the
effects of adrenaline and noradrenaline were identical, solely experi-
ments with more frequently used noradrenaline are described below.
Overall, more than 500MSCs were distinguished by their ability to gen-
erate robust and reproducible Ca2+ transients on noradrenaline and its
analogs. We ﬁrst attempted to evaluate a part of Ca2+ release and Ca2+
entry, the primary contributors to intracellular Ca2+ signaling, in
noradrenaline responses. It was particularly found that the inhibitor of
phospholipase C (PLC) U73122 (1–5 μM) rendered MSCs insensitive to
noradrenaline, while the much less effective analog U73343 never
exerted such effects at concentrations of up to 10 μM (Fig. 2A) (n =
17). Besides, 2-APB known to inhibit IP3 receptors damped noradrena-
line responses aswell (Fig. 2B) (n= 11). Note that 2-APBmight also in-
hibit Ca2+ entry by exerting blockage of certain Ca2+-permeable
channels [23–25]. However, the reduction of bath Ca2+ from 2 mM to
260 nM inﬂuenced the sensitivity of adrenergic MSCs rather than the
magnitude of noradrenaline responses (Fig. 2B, C). It thus appeared
that in MSCs, the IP3 receptor was a principal target for 2-APB. Indeed,
overall 317 noradrenaline-sensitive MSCs were examined with normal
(2mM) and low (260 nM) Ca2+ in the bath. In all cases, MSC responses
to saturating noradrenaline depended weakly or negligibly on the
extracellular Ca2+, while with 260 nM Ca2+ in the bath, cells became
irresponsive at intermediate agonist concentrations (Fig. 2C). Thus,
adrenergic transduction relies largely on Ca2+ release mediated by
PLC and IP3 receptors. Although bath Ca2+ somehow affected MSC
sensitivity, to all appearance, Ca2+ entry determined the magnitude of
noradrenaline responses to a little extent.
3.1. Dose–response curve
The interesting feature of adrenergic MSCs was that Ca2+ responses
variedwith noradrenaline concentration in a surprising “all-or-nothing”
fashion (Fig. 3). In other words, noradrenaline never caused detectableeffects, when applied below100 nM,while at exceeding concentrations,
it elicited marked Ca2+ transients of maximal or close magnitude in
most cases (Fig. 3A, B). In designated experiments, we evaluated the
dose–response curves of individual cells by stimulating them with
noradrenaline at gradually varied concentrations. Among the 37 cells
examined, 29 cells exhibited robust responses in the whole range of
agonist concentrations (30 nM–10 μM) (e.g. Fig. 3B) with the threshold
of 100–200 nM (Fig. 3C, D). We categorized adrenergic MSCs into two
groups based on their dose–response curves. One included possibly
most robust cells (n = 21), which responded to noradrenaline with
similar Ca2+ transients irrespective of agonist concentration (Fig. 3B,
C). Another group (n = 8) united cells with somewhat irregular dose
dependencies (Fig. 3D). Among them, 5 cells exhibited large (65–75%)
but not maximal responses at the threshold stimulation and generated
increasing Ca2+ transients on rising noradrenaline (Fig. 3D). Three
cells generated the maximal responses at the threshold but showed ir-
regularly varied lower responses as agonist concentration increased.
Fig. 2. Evidence for a role of the phosphoinositide cascade in noradrenaline transduction.
(A) Representative effects of the PLC inhibitor U73122 (1 μM) and its much less effective
analog U73343 (1 μM) on MSC responsivity to 0.5 μM noradrenaline. (B) 2-ABP (50 μM)
reversibly suppressed noradrenaline responses. Notably, a given cell similarly responded
to 0.5 μM noradrenaline with normal (2 mM) and reduced (260 nM) Ca2+ in the bath.
This data and the recording presented in (C) indicate conclusively that 2-APB ruined nor-
adrenaline transduction largely due to the inhibition of IP3-receptors rather than Ca2+
entry. (C) Representative recording froma cell that lost sensitivity to 0.5 μMnoradrenaline
at low external Ca2+.With 260nMCa2+ in the bath, this cell did not respond to the agonist
at 0.5 μM and 1 μM but was still responsive to 2.5 μM noradrenaline. Although the reduc-
tion of bath Ca2+ from 2 mM to 260 nM reversibly decreased the sensitivity of MSCs, the
magnitude of noradrenaline responseswas virtually independent of bath Ca2+. In (A–C), 3
different cells were assayed. Extracellular Ca2+was not completely removed as prolonged
exposure of assayed cells to a Ca2+-free solution might shorten their lifespan and inacti-
vate them. Here and in the below ﬁgures, short lines above ﬂuorescence traces show tran-
sient applications of indicated compounds; the time course of bath Ca2+ is marked by the
continuous lines.
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of them exhibited small Ca2+ responses to noradrenaline at the thresh-
old concentrations (Fig. 3).
One more notable feature of noradrenaline responses was that they
were markedly postponed relative to a moment of agonist application.
The characteristic time of response delay (τd, Fig. 3E) gradually de-
creased with noradrenaline concentration (Fig. 3F). Particularly, Ca2+
transients were retarded by 38–55 s at the threshold stimulation
(Fig. 3E, left response), whereas the delay was reduced to 17–26 s at
the concentration of 1 μM and higher (Fig. 3E, right response), albeit
response magnitude was not so variable (Fig. 3E). As discussed
later, two primary mechanisms may be responsible for speciﬁc
dependencies of the magnitude and delay of cellular responses on
agonist concentration.
3.2. Ca2+-induced Ca2+ release as a likely contributor
A variety of diverse cells exemplify a monotonic and gradual depen-
dence of cellular responses on agonist concentration, including those
that employ the phosphoinositide cascade for coupling GPCRs to Ca2+
mobilization [26–28]. All-or-nothing responses of MSCs to noradrena-
line (Fig. 3) could hardly be accounted for by a transduction processthat involves solely PLC stimulation and IP3 production followed by
Ca2+ release via IP3 receptors (Fig. 2). We therefore assumed that
MSCs generated responses to noradrenaline in two consecutive steps.
Initially, the agonist triggered small Ca2+ signal presumably gradually
dependent on stimulus intensity. When exceeded the threshold, this
signal was then ampliﬁed to the saturated level by a Ca2+-dependent
trigger. Well-documented among numerous cell types, Ca2+-induced
Ca2+ release (CICR) might serve such a role [29–31].
If this idea is correct, every noradrenaline-independent Ca2+ signal
in the MSC cytoplasm, should it be speedy and high enough, would be
converted by CICR into a noradrenaline-like Ca2+ response.We particu-
larly wondered how adrenergic cells would react to a jump in cytosolic
Са2+ produced by photolysis of NP-EGTA. The last is a photosensitive
Ca2+ chelator with high afﬁnity to Са2+ (Kd ~ 10−7М), so that in a ris-
ing cell (~100 nm free Са2+), nearly half NP-EGTAmolecules are bound
to Са2+ ions. The absorption of ultraviolet (UV) light by NP-EGTA dis-
rupts the coordination sphere responsible for Ca2+ binding, thus liber-
ating Ca2+ ions and producing a step-like increase in cytosolic Ca2+
[32]. In appropriate experiments, cells were loaded with both Fluo-4
and NP-EGTA, and their responses to noradrenaline and UV pulses
were studied. Note that a UV laser used by us was in fact a biharmonic
light source emitting at 355 nmand532 nm. Since powerful green emis-
sion could not be completely eliminated with excitation ﬁlters, a light
stimulus produced an optical artifact that was seen as a marked over-
shoot in an experimental recording of cell ﬂuorescence acquired at
535 ± 20 nm.
The representative trace plotted in Fig. 4A illustrates typical Ca2+
signals elicited byUVﬂashes, durations ofwhichwere varied to produce
different Ca2+ bursts in the MSC cytoplasm. Here and in other cases
(n = 33), light stimuli triggered two fundamentally different types
of Ca2+ responses. The relatively short, 2-s in the given case, UV pulse
produced an optical artifact that was followed by a small Ca2+ jump
without evident delay (Fig. 4A, response 1 and Fig. 4B, thick line). This
Ca2+ signal exhibited exponential relaxation presumably mediated by
Ca2+ pumps. The sequential 4-s and 6-s UV ﬂashes elicited biphasic
Ca2+ transients of non-proportional magnitudes (Fig. 4A). Indeed, com-
pared to a 2-s UV pulse, one could expect 4-s and 6-s light stimuli to lib-
erate nearly twice and three times more Ca2+ ions, respectively.
Meanwhile, 4-s, 6-s, and 8-s ﬂashes usually triggered the similar Ca2+
transients that exceeded a response to a 2-s pulse by an order of magni-
tude (Fig. 4A). With the exception of CICR, none of the known Ca2+-
dependent mechanisms could amplify and shape an initial Ca2+ signal
produced by the NP-EGTA photolysis in such a way (Fig. 4A, response 1
vs. response 2). In addition, the representative cell (Fig. 4A) was insensi-
tive to 50 nMnoradrenaline but similarly responded to the agonist at the
0.5 μM and 1 μM concentrations. Notably, the noradrenaline responses
and light responses were quite similar in their shape and magnitude
(Fig. 4B, thin line and circles). Similar results were obtained with other
8MSCs that tolerated prolonged serial stimulationwith bothUVandnor-
adrenaline. The overall data are partly summarized in Fig. 4C. Here each
symbol represents agonist response versus light response, both being re-
corded from the same cell sequentially stimulated by a 6-s UV pulse and
0.5 μM noradrenaline (Fig. 4A). The linear regression with the slope of
0.96 (solid line) satisfactorilyﬁts the depicted data. Thus, themarked fea-
ture of adrenergic MSCs was all-or-nothing responsivity to both nor-
adrenaline and Ca2+ uncaging. Besides, Ca2+ transients elicited by the
agonist and light were very close kinetically and by magnitude.
Theoretically, Ca2+ uncaging could stimulate Ca2+-dependent PLC
[33,34]. This would result in IP3 production and Ca2+ release, thereby
simulating noradrenaline responses. To check such a possibility, several
adrenergic MSCs (n= 7) loaded with NP-EGTAwere subjected to Ca2+
uncaging in the presence of U73122. Although this PLC inhibitor expect-
edly rendered cells irresponsive to noradrenaline, they normally
responded to UV ﬂashes (Fig. 4D). These ﬁndings left little doubt that
Ca2+ uncaging elicited noradrenaline-like responses exclusively by trig-
gering CICR in the MSC cytoplasm. This inference was completely
Fig. 3.Dose dependence of noradrenaline responses. (A, B) Representative recordings of intracellular Ca2+ in twoMSCs stimulated by noradrenaline in series. Each cellwas irresponsive to
noradrenaline at 100 nM and lower doses but generated Ca2+ responses that subtly varied with agonist concentration within the 100 nM–10 μM range. (C) Superimposed dose depen-
dences of noradrenaline responses recorded from 21 cells that exhibited small or negligible dependence of Ca2+ transients on noradrenaline concentration above the threshold. The last
varied from cell to cell between 100 and 200 nM (gray bar). (D). Summary of recordings obtained from 8 cells showed divers and irregular dose–response dependencies. In (C, D),
responses of a given cell were normalized to a response produced by 1 μM noradrenaline. Each symbol corresponds to an individual cell. (E) Representative recording of Ca2+ transients
elicited by noradrenaline at 100 nM (threshold concentration) and 500 nM. These responseswere delayed relative to themoment of agonist application by 55 s and 16 s, respectively. The
characteristic time of the response delay (τd) was calculated as a time interval necessary for a Ca2+ transient to reach the half-magnitude value (left panel). (F) Dependence of response
delay on noradrenaline concentration. The data are obtained from 8 different cells and presented as a mean ± S.D. (n = 5–8).
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waves in MSCs (Supplementary Fig. 2S).
At the moment solely ryanodine and inositol 1,4,5-trisphosphate
(IP3) receptors, both being Ca2+-gated Ca2+-release channels operating
in the endo/sarcoplasmic reticulum are known to mediate CICR in a
variety of different cells [31,33,35]. A number of noradrenaline respon-
siveMSCs (n=17)were pre-incubatedwith 50 μMryanodine for about
200 s. Although ryanodine receptors should have been inhibited
completely under these conditions, sensitivity of such cells to noradren-
aline altered insigniﬁcantly (Fig. 5A). In contrast, MSCs were rendered
irresponsive by 2-APB (50 μM), an IP3 receptor antagonist (Fig. 5A)
(n = 15). Moreover, in experiments, wherein cells loaded with NP-
EGTA were stimulated by both noradrenaline and UV pulses, ryanodinedid not suppress responses to either of the stimuli, whereas 2-APB
reversibly inhibited CICR initiated by Ca2+ uncaging (n = 7) (Fig. 5B).
It thus appears that just IP3 receptors are mainly responsible for CICR
in adrenergic MSCs. This inference is consistent with the work by
Kawano et al. [36], which found no evidence for the expression of
ryanodine receptors but detected transcripts for all three IP3 receptor
isoforms in MSCs derived from the human bone marrow.
3.3. Adrenoreceptor subtypes
In light of the abovementioned functional tests, we were interested
in the molecular identity of adrenoreceptors operative in MSCs. The
RT-PCR analysis was performed using RNA isolated from multiple MSC
Fig. 4. Evidence for Ca2+-induced Ca2+ release in adrenergic MSCs. (A) Responses of a NP-EGTA loaded cell to UV ﬂashes of varied durations and to noradrenaline at the indicated con-
centrations. (B) Superimposition of the responses numbered as 1, 2, and 3 in (A). (C) Noradrenaline response versus light response, both being expressed as ΔF/F0. The straight line
with the slope of 0.96 represents linear regression. The analyzed responses were sequentially elicited by light and 0.5 μM noradrenaline. Each symbol corresponds to the particular cell
(D) PLC inhibitor U73122 dumped MSC responsiveness to noradrenaline but did not prevent noradrenaline response-like Ca2+ transients produced by Ca2+ uncaging.
Fig. 5. Noradrenaline transduction and CICR in MSCs rely largely on IP3 receptors. (A, B)
Ryanodine receptor blockage with 50 μM ryanodine entailed an insigniﬁcant change in
cell responsivity to noradrenaline and UV light. In contrast, responses to both the agonist
and Ca2+ uncaging were completely abolished by the IP3 receptor inhibitor 2-APB
(50 μM). The traces in (A) and (B) were scaled identically.
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donors. Speciﬁc primers were designed based on available sequences
of all 9 genes encoding human adrenoreceptors [37] (Supplementary
Table 1S). It is noteworthy that all RNA samples contained tran-
scripts for α1B-, α2A-, and β2-adrenoreceptors as well as for CD73,
CD90, and CD105 (Fig. 6) that are conventionally considered as
MSC markers [4,38]. The expression of α1- and α2-adrenoreceptors
in MSCs was also conﬁrmed at the protein level using subtype-
speciﬁc antibodies for immunostaining. It turned out that each tested
MSC colony (n = 7) contained a small (2–4%) subpopulation of cells
exhibiting α1- and α2-like immunoreactivity (Fig. 6B, C). Although
the α1-adrenoreceptor is ubiquitously involved in Ca2+ signaling [39],
coupling of the α2 isoform to PLC and Ca2+ mobilization has also
been documented [40]. Thus, the expression of α1B or α2A or both
isoforms in a MSC responsive to noradrenaline (Fig. 2) would be quite
relevant. In contrast, β2-adrenoreceptors are generally coupled by
G-proteins to adenylate cyclase [41], and those should not necessarily
be present in a MSC generating Ca2+ transients to noradrenaline. It
was therefore unclear whether the detected adrenoreceptors (Fig. 6)
were expressed in the same cell or there were separate MSC subpopu-
lations distinguishable by speciﬁc expression proﬁles of these receptor
proteins.
Fig. 6. Adrenoreceptors speciﬁcally expressed in MSCs. (A) Representative RT-PCR analysis of expression of human adrenoreceptors in a MSC population (105–106 cells). The
detected transcripts correspond to the α1B-, α2A-, and β2-isoforms and are seen as amplicons of the expected sizes of 379, 347, and 218 bp, respectively. Apart from these
adrenoreceptor transcripts, each mRNA preparation also contained transcripts for CD73 (266 bp), CD90 (344 bp), and CD105 (300 bp) conventionally considered as MSC
markers. The molecular weight markers (M) were from GeneRuler 100 bp DNA Ladder (Fermentas). Their sizes (bp) are indicated by the digits at the left of the corresponding
lane (M) in the presented 1.2% agarose gel stained with ethidium bromide. (B) Fluorescent imaging of a MCS colony treated with primary mouse antibody against the human α1
adrenoreceptor and stained with secondary antibody Alexa goat anti-mouse 488. (C) Fluorescent imaging of a MCS colony treated with primary rabbit antibody against the
humanα2-adrenoreceptor and stained with secondary antibody Alexa goat anti-rabbit 488. In (B) an (C), cells were counterstained with nuclear 4,6-diamidino-2-phenylindole.
The adrenoreceptor-positive cells are greenish.
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and antagonists speciﬁc for the α1-, α2-, and β-subtypes in the
adrenoreceptor family. Overall, 35 noradrenaline-responsive cells
were treated with phenylephrine and/or cirazoline and prazosin
(α1-agonists and antagonist, respectively) as well as with
guanobenz and/or B-HT 933 and yohimbine (α2-agonists and
antagonist, respectively). Most of them (29 cells, 83%) were irre-
sponsive to phenylephrine (1–10 μM), and their noradrenaline
responses were not inhibited by 10 μM prazosin. In contrast,
guanobenz (50 μM) and B-HT 933 (10 μM) were quite effective
(Fig. 7A, B). Moreover, 1 μM yohimbine dumped cellular responses
to noradrenaline and guanobenz (Fig. 7A, B). Six cells (17%) were
sensitive to both 10 μM phenylephrine and 10 μM guanobenz
(Fig. 7C). These ﬁndings indicate that the α2-subtype, evidently
α2A is the dominant adrenoreceptor, although in a minor MSC sub-
population, both α1- and α2-isoforms could be involved in adrenergic
transduction.
In a number of experiments, we aimed at β-adrenoreceptors by
treating noradrenaline-responsive MSCs with the β-agonist isopro-
terenol and β-antagonist alprenolol. Isoproterenol (1–10 μM) as
such negligibly affected intracellular Ca2+ at rest and insigniﬁcantly
modulated cell responsivity to noradrenaline (n = 9) (Fig. 7D). Sur-
prising in light of this ﬁnding was that all assayed cells became irre-
sponsive in the presence of alprenolol (5–10 μM) that acted
reversibly (n = 16) (Fig. 7D). At the moment we have no validated
explanation of this phenomenon. In any event, the described effects
of the subtype speciﬁc agonists and antagonists (Fig. 7) can be con-
sidered as an indication that all adrenoreceptor isoforms detected
by RT-PCR are functional in MSCs. Moreover, the data provide func-
tional evidence that α2- and β2-subtypes are co-expressed.4. Discussion
Here we studied Ca2+ signaling in mesenchymal stromal cells
(MSCs) derived from the human adipose tissue. As a whole, a popula-
tion of cultured MSCs exhibited functional heterogeneity in terms of
their responsivity to a variety of GPCR agonists, including ATP, GABA,
noradrenaline and some others. Although all ﬁrst messengers tested
were effective, only a relatively small group of MSCs was speciﬁcally
responsive to the particular agonist (Fig. 1). Consistently with previous
reports (reviewed in [9]), someMSCs thatwere basically irresponsive to
the agonists generated spontaneous Ca2+ oscillations under our re-
cording conditions (Fig. 1).
The present work was speciﬁcally focused on adrenergic MSCs.
The physiological analysis, RT-PCR, and immunostaining revealed
the functional expression of α1B-, α2A-, and β2-adrenoreceptors
(Figs. 6 and 7). The experiments with the subtype speciﬁc agonists
pointed at the α2A-isoform as a key adrenoreceptor endowing
MSCs with sensitivity to noradrenaline, although α1B-isoform also
might be involved (Fig. 7). Theβ-agonist isoproterenol negligibly affect-
ed intracellular Ca2+ in resting MSCs and their sensitivity to noradren-
aline (Fig. 7D), indicating that β2-adrenoreceptors are not directly
coupled to Ca2+mobilization inMSCs. In light of this ﬁnding, surprising
was that cells became insensitive to noradrenaline in the presence of
alprenolol (Fig. 7D) that normally antagonizes to G-protein signaling
initiated by classical agonists of β-adrenoreceptors. Although underly-
ingmechanism(s) remains to be elucidated, theoretically, the inhibitory
effects of alprenolol could be rationally explained based on the concept
of biased agonism [42–44]. Indeed, this compound has been document-
ed to stimulate coupling of β1- and β2-adrenoreceptors to ERK1/2
kinase via β-arrestin [45,46]. It is therefore possible that alprenolol
Fig. 7. Sensitivity of MSC to various adrenergic agonists and antagonists. (A, B) Most (83%) of noradrenaline-sensitive MSCs also responded to the α2-receptor agonists
guanobenz and B-HT 933 but not to phenylephrine and cirazoline, α1-receptor agonists. Consistently, Ca2+ responses to noradrenaline and guanobenz were markedly diminished in
the presence of yohimbine, an α2 antagonist, while the α1 antagonist prazosin was ineffective. (C) Small subpopulation (17%) of noradrenaline-sensitive cells responded to both α2
and α1 agonists. (D) Representative recording of intracellular Ca2+ in a cell stimulated by noradrenaline in control and in the presence of the β-agonist isoproterenol and β-antagonist
alprenolol.
1906 P.D. Kotova et al. / Biochimica et Biophysica Acta 1843 (2014) 1899–1908affected noradrenaline responses (Fig. 7D) by stimulating β2-
adrenoreceptors as a biased agonist capable of initiating β-arrestin
signaling, currently unidentiﬁed inMSCs. This arrestin-dependent path-
way might interfere with the adrenergic transduction machinery,
rendering MSCs irresponsive.
The body of evidence implicates the classical phosphoinositide
cascade in mediating adrenergic signaling in MSCs. In particular, nor-
adrenaline responses were speciﬁcally suppressed by the PLC inhibitor
U73122 and IP3 receptor blocker 2-APB (Fig. 2). Hence, PLC stimulation,
IP3 production, and IP3 receptor activation appear to be obligatory
events in noradrenaline transduction. Yet, the reduction of bath Ca2+
from 2 mM to 260 nM subtly affected the kinetics and magnitude of
MSC responses to saturating noradrenaline but rendered cells less sen-
sitive to the agonist at intermediate concentrations (Fig. 2B, C). To all
appearance, Ca2+ entry plays a minor role in adrenergic Ca2+ signaling
that relies largely on Ca2+ exchange between Ca2+ stores and the MSC
cytoplasm. It is currently unclear what mechanism(s) could underlie
the decreased MSC sensitivity to adrenergic agonists at low bath Ca2+.
Note however that our preliminary results point at extracellular Ca2+
sensing receptor (CASR) to be expressed in MSCs (data not shown). It
is not unlikely that as a bath Ca2+ sensor, just CASR is responsible for
the Ca2+-dependent modulation of MSC sensitivity to noradrenaline
(Fig. 2C).The responsivity of adrenergicMSCs followed a peculiar dose depen-
dence: noradrenalinenever elicited small or intermediate responses but
initiated Ca2+ transients basically being large and quite similar at all
concentrations above the threshold. A number ofMSCs exhibited robust
noradrenaline responses within 30–40 min, thus allowing for the reli-
able assay of their responsivity over a wide range of agonist concentra-
tions (Fig. 3A, B). These cells exhibited step-like dose dependences with
the threshold noradrenalin concentration of 100–200 nM (Fig. 3C). In
many cases, responses of MSCs to adrenergic agonists varied with
time and/or were liable to rundown. Presumably, such cells showed
somewhat irregular dose–response curves like those depicted in
Fig. 3D. Even so, all obtained dose dependencies evidence for the all-
or-nothing character of noradrenaline responsivity.
Amazingly, the key features of noradrenaline responses, including
the all-or-nothing behavior, were correctly simulated with Ca2+
uncaging, provided that it produced sufﬁcient Ca2+ bursts in the MSC
cytoplasm (Fig. 4). In more detail, short UV pulses elicited relatively
small Ca2+ transients that relaxed monotonically. In contrast, more
prolonged light stimuli, which liberated sufﬁcient quantity of Ca2+
ions, triggered biphasic Ca2+ signals that were rather similar to nor-
adrenaline responses by kinetics and magnitude (Fig. 4A, B). Based on
these ﬁndings, we inferred that adrenergic transduction occurs in two
key steps. Initially, an adrenergic agonist produces a relatively small
Fig. 8.Minimal model of adrenergic transduction in MSCs. The adrenoreceptor is coupled
by a G-protein to PLC, so that an adrenergic agonist initiates PIP2 hydrolysis and IP3
production followed by stimulation of a related IP3 receptor (IP3Rgrad). Next, Ca2+ is
released from Ca2+ store, producing an initial Ca2+ signal, gradually rising with agonist
concentration (red curve). As soon as this signal reaches the threshold level (dotted
line), one stimulates IP3 receptors of another type (IP3RCICR) in separated Ca2+ store and
triggers a regenerative process via CICR. This results in a much larger Ca2+ transient of a
shape and magnitude virtually independent of agonist concentration (blue curve).
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given that the experimentally recorded Ca2+ transients were delayed
relative to noradrenaline application in a dose-dependent way (Fig. 3E,
F). When reaching the threshold level, this initial Ca2+ signal triggers a
regenerative process mediated by the CICR mechanism that eventually
produces a global Ca2+ response of the maximal value (Fig. 3A, B).
Although qualitatively, the above point of view integrates well the
diverse ﬁndings of the present work, two apparent inconsistencies
should be noted. The ﬁrst relates to the nature of all-or-nothing Ca2+
signals elicited by adrenergic agonists. One could expect that an initial
agonist-dependent Ca2+ rise preceding CISR should have been present
in recording traces (Fig. 3A, B), as is the case with Ca2+ signals initiated
by Ca2+ uncaging (Figs. 4A, 5). It is noteworthy that even confocal
microscopy did not allow us to achieve high enough spatial/temporal
resolution to separate a triggering noradrenaline-dependent Ca2+ sig-
nal from CISR in the MSC cytoplasm (data not shown). Unlike Ca2+
uncaging that elicited a global and therefore resolvable Ca2+ rise
(Fig. 4A), an initial Ca2+ response to noradrenaline was most likely
generated in a very narrow cytosolic region near the plasma mem-
brane. Given that Fura-4 and other Ca2+ dyes uniformly distributed
in the cell cytoplasm do not allow for detecting such signals, geneti-
cally targetable Ca2+ indicators [47] may be necessary to address this
problem.
Another point is that the effects of ryanodine and 2-APB on nor-
adrenaline and UV light responses (Figs. 2, 5A) favor IP3 receptors
to be largely, if not exclusively, responsible for CICR in adrenergic
MSCs. Furthermore, the negligible effects of the PLC inhibitor
U73122 on UV responses (Fig. 4D) suggest that CICR in MSCs does
not require IP3 production. It thus appears that adrenergic trans-
duction implicates IP3 receptors in two fundamentally different
signaling events, one requiring PLC stimulation and another being
PLC-independent. Note however that intracellular signaling in-
volves distinct subpopulations of IP3 receptors that differ in their
sensitivity to IP3 and Ca2+ and may operate in physically separated
Ca2+ compartments [31,48]. The necessary functional specializa-
tion of IP3 receptors can also be achieved with the assistance of
the Са2+-binding protein CIB1 that stimulates all three IP3R iso-
forms in a Ca2+-dependent manner even in the absence of IP3
[49]. Thus, under certain conditions, IP3 receptor-mediated CICR
may not require IP3 production (Fig. 4D).5. Conclusions
Based on the main ﬁnding of the present study, we propose the
following minimal model of adrenergic transduction in MSCs (Fig. 8).
Adrenergic receptors are coupled via certain G-proteins, PLC, and IP3
production to IP3 receptors (IP3Rgrad) to release Ca2+ from designated
Ca2+ store, resulting in an initial, presumably gradual Ca2+ signal. The
last stimulates specialized IP3 receptors (IP3RCICR) operative in separat-
ed Ca2+ store, thus triggering CICR that ﬁnalizes Ca2+ responses to
adrenergic agonists. Finally, note that in a given MSC preparation, the
number of cells responsive to Ca2+ uncagingwith CICR (Fig. 4A) usually
exceeded the number of cells responsive to adrenergic agonists. This
suggests that the CICR mechanism not only mediates adrenergic trans-
duction but may also be involved in Ca2+ signaling initiated in MSCs
by other ﬁrst messengers (Fig. 1A).Acknowledgements
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